Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (39)
Rachel Fasiczka, Yahaira Naaldijk, Besma Brahmia & Sabine Hilfiker. (2023) Insights into the cellular consequences of LRRK2-mediated Rab protein phosphorylation. Biochemical Society Transactions.
Crossref
Crossref
Susanna Cogo, Franz Y. Ho, Elena Tosoni, James E. Tomkins, Isabella Tessari, Lucia Iannotta, Thomas J. Montine, Claudia Manzoni, Patrick A. Lewis, Luigi Bubacco, Marie-Christine Chartier Harlin, Jean-Marc Taymans, Arjan Kortholt, Jeremy Nichols, Laura Cendron, Laura Civiero & Elisa Greggio. (2022) The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation. Brain Research 1778, pages 147781.
Crossref
Crossref
Lucia Iannotta & Elisa Greggio. (2021) LRRK2 signaling in neurodegeneration: two decades of progress. Essays in Biochemistry 65:7, pages 859-872.
Crossref
Crossref
Federica Bono, Veronica Mutti, Paola Devoto, Silvia Bolognin, Jens C. Schwamborn, Cristina Missale & Chiara Fiorentini. (2021) Impaired dopamine D3 and nicotinic acetylcholine receptor membrane localization in iPSCs-derived dopaminergic neurons from two Parkinson’s disease patients carrying the LRRK2 G2019S mutation. Neurobiology of Aging 99, pages 65-78.
Crossref
Crossref
Xi Chen, Chengsong Xie, Wotu Tian, Lixin Sun, Wang Zheng, Sarah Hawes, Lisa Chang, Justin Kung, Jinhui Ding, Shengdi Chen, Weidong Le & Huaibin Cai. (2020) Parkinson’s disease-related Leucine-rich repeat kinase 2 modulates nuclear morphology and genomic stability in striatal projection neurons during aging. Molecular Neurodegeneration 15:1.
Crossref
Crossref
Bethany J. Sanstrum, Brandee M. S. S. Goo, Diana Z. Y. Holden, Donovan D. Delgado, Thien P. N. Nguyen, Kiana D. Lee & Nicholas G. James. (2020) Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics. Molecules 25:11, pages 2561.
Crossref
Crossref
Rauan Kaiyrzhanov, Akbota Aitkulova, Chingiz Shashkin, Nazira Zharkinbekova, Mie Rizig, Elena Zholdybayeva, Zharkyn Jarmukhanov, Vadim Akhmetzhanov, Gulnaz Kaishibayeva, Talgat Khaibullin, Altynay Karimova, Serik Akshulakov, Askhat Bralov, Nurlan Kissamedenov, Zhanar Seidinova, Anjela Taskinbayeva, Aliya Muratbaikyzy & Henry Houlden. (2020) LRRK2 Mutations and Asian Disease-Associated Variants in the First Parkinson’s Disease Cohort from Kazakhstan. Parkinson's Disease 2020, pages 1-10.
Crossref
Crossref
Beatrice Weykopf, Simone Haupt, Johannes Jungverdorben, Lea Jessica Flitsch, Matthias Hebisch, Guang‐Hui Liu, Keiichiro Suzuki, Juan Carlos Izpisua Belmonte, Michael Peitz, Sandra Blaess, Andreas Till & Oliver Brüstle. (2019)
Induced pluripotent stem cell‐based modeling of mutant
LRRK
2‐associated Parkinson's disease
. European Journal of Neuroscience 49:4, pages 561-589.
Crossref
Crossref
Laura Civiero, Susanna Cogo, Alice Biosa & Elisa Greggio. (2018) The role of LRRK2 in cytoskeletal dynamics. Biochemical Society Transactions 46:6, pages 1653-1663.
Crossref
Crossref
V. V. Simonova, A. S. Vetchinova, E. V. Novosadova, L. G. Khaspekov & S. N. Illarioshkin. (2018) Genome Editing and the Problem of Tetraploidy in Cell Modeling of the Genetic Form of Parkinsonism. Biochemistry (Moscow) 83:9, pages 1040-1045.
Crossref
Crossref
Laura Pellegrini, Andrea Wetzel, Simone Grann?George Heaton & Kirsten Harvey. (2016) Back to the tubule: microtubule dynamics in Parkinson?s disease. Cellular and Molecular Life Sciences 74:3, pages 409-434.
Crossref
Crossref
Jin Li, Limei Wang, Tao Jiang, Jizhe Wang, Xue Li, Xiaoyan Liu, Chunyu Wang, Zhixia Teng, Ruijie Zhang, Hongchao Lv & Maozu Guo. (2016) eSNPO: An eQTL-based SNP Ontology and SNP functional enrichment analysis platform. Scientific Reports 6:1.
Crossref
Crossref
Md Shariful Islam, Hendrik Nolte, Wright Jacob, Anna B. Ziegler, Stefanie P?tz, Yael Grosjean, Karolina Szczepanowska, Aleksandra Trifunovic, Thomas Braun, Hermann Heumann, Rolf Heumann, Bernhard Hovemann, Darren J. Moore & Marcus Kr?ger. (2016)
Human R1441C LRRK2 regulates the synaptic vesicle proteome and phosphoproteome in a
Drosophila
model of Parkinson?s disease
. Human Molecular Genetics, pages ddw352.
Crossref
Crossref
Bo Ma, Leyan Xu, Xiaodong Pan, Lixin Sun, Jinhui Ding, Chengsong Xie, Vassilis E. Koliatsos & Huaibin Cai. (2016) LRRK2 modulates microglial activity through regulation of chemokine (C–X3–C) receptor 1 –mediated signalling pathways. Human Molecular Genetics 25:16, pages 3515-3523.
Crossref
Crossref
Liron Rozenkrantz, Ziv Gan-Or, Mali Gana-Weisz, Anat Mirelman, Nir Giladi, Anat Bar-Shira & Avi Orr-Urtreger. (2016) SEPT14 Is Associated with a Reduced Risk for Parkinson’s Disease and Expressed in Human Brain. Journal of Molecular Neuroscience 59:3, pages 343-350.
Crossref
Crossref
Sara Saez-Atienzar, Luis Bonet-Ponce, Carmen da Casa, Laura Perez-Dolz, Jose R. Blesa, Eduardo Nava, Maria F. Galindo & Joaquín Jordan. (2016) Bcl-xL-mediated antioxidant function abrogates the disruption of mitochondrial dynamics induced by LRRK2 inhibition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:1, pages 20-31.
Crossref
Crossref
Guoxiang Liu, Carmelo Sgobio, Xinglong Gu, Lixin Sun, Xian Lin, Jia Yu, Loukia Parisiadou, Chengsong Xie, Namratha Sastry, Jinhui Ding, Kelly M. Lohr, Gary W. Miller, Yolanda Mateo, David M. Lovinger & Huaibin Cai. (2015)
Selective expression of Parkinson's disease-related
Leucine-rich repeat kinase 2
G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression
. Human Molecular Genetics 24:18, pages 5299-5312.
Crossref
Crossref
Truong-Minh Dang, Wing-Cheong Wong, Siew-Min Ong, Peng Li, Josephine Lum, Jinmiao Chen, Michael Poidinger, Francesca Zolezzi & Siew-Cheng Wong. (2015) MicroRNA expression profiling of human blood monocyte subsets highlights functional differences. Immunology 145:3, pages 404-416.
Crossref
Crossref
Enzhu Jiang, Fengrui Li, Chenchen Jing, Pei Li, Honggang Cui, Baojie Wang, Mei Ding & Hao Pang. (2015)
High-Resolution Melting Analysis as a Developed Method for Genotyping the PD Susceptibility Loci in
LRRK2
Gene
. Journal of Clinical Laboratory Analysis 29:4, pages 299-304.
Crossref
Crossref
Marta Garcia-Miralles, Janaky Coomaraswamy, Karina H?big, Martin C. Herzig, Natalja Funk, Frank Gillardon, Martina Maisel, Mathias Jucker, Thomas Gasser, Dagmar Galter & Saskia Biskup. (2015) No Dopamine Cell Loss or Changes in Cytoskeleton Function in Transgenic Mice Expressing Physiological Levels of Wild Type or G2019S Mutant LRRK2 and in Human Fibroblasts. PLOS ONE 10:4, pages e0118947.
Crossref
Crossref
Pablo Porras, Margaret Duesbury, Antonio Fabregat, Marius Ueffing, Sandra Orchard, Christian Johannes Gloeckner & Henning Hermjakob. (2015) A visual review of the interactome of LRRK2: Using deep‐curated molecular interaction data to represent biology. PROTEOMICS 15:8, pages 1390-1404.
Crossref
Crossref
M. Caesar, S. Felk, J.O. Aasly & F. Gillardon. (2015) Changes in actin dynamics and F-actin structure both in synaptoneurosomes of LRRK2(R1441G) mutant mice and in primary human fibroblasts of LRRK2(G2019S) mutation carriers. Neuroscience 284, pages 311-324.
Crossref
Crossref
Jianfeng Xiao, Satya Vemula & Zhenyu Yue. 2015. Movement Disorders. Movement Disorders
307
328
.
A. Raquel Esteves, Russell H. Swerdlow & Sandra M. Cardoso. (2014) LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis. Experimental Neurology 261, pages 206-216.
Crossref
Crossref
Bingwei Lu. (2014)
LRRK
2 directing
ER
‐to‐
G
olgi transport? (
ER
)y
ES
!
. The EMBO Journal 33:20, pages 2279-2280.
Crossref
Crossref
Hyun Jin Cho, Jia Yu, Chengsong Xie, Parvathi Rudrabhatla, Xi Chen, Junbing Wu, Loukia Parisiadou, Guoxiang Liu, Lixin Sun, Bo Ma, Jinhui Ding, Zhihua Liu & Huaibin Cai. (2014)
Leucine‐rich repeat kinase 2 regulates Sec16A at
ER
exit sites to allow
ER
–Golgi export
. The EMBO Journal 33:20, pages 2314-2331.
Crossref
Crossref
Mary Ann Chapman. (2014) Interactions between cell adhesion and the synaptic vesicle cycle in Parkinson’s disease. Medical Hypotheses 83:2, pages 203-207.
Crossref
Crossref
Isabella Russo, Luigi Bubacco & Elisa Greggio. (2014) LRRK2 and neuroinflammation: partners in crime in Parkinson?s disease?. Journal of Neuroinflammation 11:1, pages 52.
Crossref
Crossref
Bernard M.H. Law, Victoria A. Spain, Veronica H.L. Leinster, Ruth Chia, Alexandra Beilina, Hyun J. Cho, Jean-Marc Taymans, Mary K. Urban, Rosa M. Sancho, Marian Blanca Ramírez, Saskia Biskup, Veerle Baekelandt, Huaibin Cai, Mark R. Cookson, Daniel C. Berwick & Kirsten Harvey. (2014) A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific β-Tubulin Isoforms Regulates Tubulin Acetylation. Journal of Biological Chemistry 289:2, pages 895-908.
Crossref
Crossref
J. Oláh, N. Tőkési, A. Lehotzky, F. Orosz & J. Ovádi. (2013) Moonlighting microtubule-associated proteins: Regulatory functions by day and pathological functions at night. Cytoskeleton 70:11, pages 677-685.
Crossref
Crossref
Mareike Caesar, Susanne Zach, Coby B. Carlson, Kathrin Brockmann, Thomas Gasser & Frank Gillardon. (2013) Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration. Neurobiology of Disease 54, pages 280-288.
Crossref
Crossref
Kelly M Hinkle, Mei Yue, Bahareh Behrouz, Justus C Dächsel, Sarah J Lincoln, Erin E Bowles, Joel E Beevers, Brittany Dugger, Beate Winner, Iryna Prots, Caroline B Kent, Kenya Nishioka, Wen-Lang Lin, Dennis W Dickson, Christopher J Janus, Matthew J Farrer & Heather L Melrose. (2012) LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors. Molecular Neurodegeneration 7:1.
Crossref
Crossref
Tatsunori Maekawa, Sayuri Mori, Yui Sasaki, Takashi Miyajima, Sadahiro Azuma, Etsuro Ohta & Fumiya Obata. (2012) The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities. Molecular Neurodegeneration 7:1.
Crossref
Crossref
Maximilian SloanJavier Alegre-AbarrateguiRichard Wade-Martins. (2012) Insights into LRRK2 function and dysfunction from transgenic and knockout rodent models. Biochemical Society Transactions 40:5, pages 1080-1085.
Crossref
Crossref
Claudia Manzoni. (2012) LRRK2 and autophagy: a common pathway for disease. Biochemical Society Transactions 40:5, pages 1147-1151.
Crossref
Crossref
Guoxiang Liu, Leonardo Aliaga & Huaibin Cai. (2012) α-synuclein, LRRK2 and their interplay in Parkinson’s disease. Future Neurology 7:2, pages 145-153.
Crossref
Crossref
José M. Bravo-San Pedro, Rubén Gómez-Sánchez, Elisa Pizarro-Estrella, Mireia Niso-Santano, Rosa A. González-Polo & José M. Fuentes Rodríguez. (2012) Parkinson's Disease: Leucine-Rich Repeat Kinase 2 and Autophagy, Intimate Enemies. Parkinson's Disease 2012, pages 1-9.
Crossref
Crossref
Zhihua Liu, Jinwoo Lee, Scott Krummey, Wei Lu, Huaibin Cai & Michael J Lenardo. (2011) The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nature Immunology 12:11, pages 1063-1070.
Crossref
Crossref
Tianxia Li, DeJun Yang, Sarah Sushchky, Zhaohui Liu & Wanli W. Smith. (2011) Models for LRRK2-Linked Parkinsonism. Parkinson's Disease 2011, pages 1-16.
Crossref
Crossref